{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:27:36Z","timestamp":1792301256116,"version":"4.4.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s11926-021-01018-6","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T11:03:51Z","timestamp":1625137431000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Reactive Arthritis Update: Spotlight on New and Rare Infectious Agents Implicated as Pathogens"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6354-6949","authenticated-orcid":false,"given":"Henning","family":"Zeidler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan P.","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,1]]},"reference":[{"key":"1018_CR1","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.berh.2015.04.009","volume":"28","author":"AJ Mathew","year":"2014","unstructured":"Mathew AJ, Ravindran V. Infections and arthritis. Best Pract Res Clin Rheumatol. 2014;28:935\u201359.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"1018_CR2","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3109\/rhe1.1969.15.issue-1-4.32","volume":"15","author":"P Ahvonen","year":"1969","unstructured":"Ahvonen P, Sievers K, Aho K. Arthritis associated with Yersinia enterocolitica infection. Acta Rheumatol Scand. 1969;15(3):232\u201353.","journal-title":"Acta Rheumatol Scand"},{"issue":"7821","key":"1018_CR3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(73)93109-7","volume":"2","author":"K Aho","year":"1973","unstructured":"Aho K, Ahvonen P, Lassus A, Sievers K, Tilikainen A. HL-A antigen 27 and reactive arthritis. Lancet. 1973;2(7821):157.","journal-title":"Lancet."},{"key":"1018_CR4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/B978-0-323-03104-2.50009-0","volume-title":"Ankylosing spondylitis and the spondyloarthropathies","author":"M Leirisalo-Repo","year":"2006","unstructured":"Leirisalo-Repo M, Sieper J. Chapter 5 - Reactive spondyloarthritis: epidemiology, clinical features, and treatment. In: Weisman MH, Reveille JD, van der Heijde D, editors. Ankylosing spondylitis and the spondyloarthropathies. Philadelphia: Mosby Elsevier; 2006. p. 53\u201364."},{"key":"1018_CR5","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/ard.58.12.737","volume":"58","author":"P Toivanen","year":"1999","unstructured":"Toivanen P, Toivanen A. Two forms of reactive arthritis? Ann Rheum Dis. 1999;58:737\u201341.","journal-title":"Ann Rheum Dis"},{"key":"1018_CR6","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1053\/berh.2002.0251","volume":"16","author":"A Keat","year":"2002","unstructured":"Keat A. Reactive arthritis or post-infective arthritis? Best Pract Res Clin Rheumatol. 2002;16:507\u201322.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1018_CR7","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/ard.58.11.661","volume":"58","author":"JG Kuipers","year":"1999","unstructured":"Kuipers JG, K\u00f6hler L, Zeidler H. Reactive or infectious arthritis. Ann Rheum Dis. 1999;58:661\u20134.","journal-title":"Ann Rheum Dis"},{"key":"1018_CR8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.berh.2006.02.003","volume":"20","author":"T Hannu","year":"2006","unstructured":"Hannu T, Inman R, Granfors K, Leirisalo-Repo M. Reactive arthritis or post-infectious arthritis? Best Pract Res Clin Rheumatol. 2006;20:419\u201333.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"1018_CR9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.rdc.2009.03.010","volume":"35","author":"JD Carter","year":"2009","unstructured":"Carter JD, Hudson AP. Reactive arthritis: clinical aspects and medical management. Rheum Dis Clin N Am. 2009;35(1):21\u201344.","journal-title":"Rheum Dis Clin N Am"},{"key":"1018_CR10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1128\/CMR.17.2.348-369.2004","volume":"17","author":"I Colmegna","year":"2004","unstructured":"Colmegna I, Cuchacovich R, Espinoza LR. HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations. Clin Microbiol Rev. 2004;17:348\u201369.","journal-title":"Clin Microbiol Rev"},{"key":"1018_CR11","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1136\/ard.61.7.580","volume":"61","author":"J Sibilia","year":"2002","unstructured":"Sibilia J, Limbach FX. Reactive arthritis or chronic infectious arthritis? Ann Rheum Dis. 2002;61:580\u20137.","journal-title":"Ann Rheum Dis"},{"key":"1018_CR12","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.berh.2006.08.008","volume":"20","author":"R Rihl","year":"2006","unstructured":"Rihl R, Klos A, Kohler L, Kuipers JG. Reactive arthritis. Best Pract Res Clin Rheumatol. 2006;20:1119\u201337.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1018_CR13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.berh.2011.05.001","volume":"25","author":"JD Carter","year":"2011","unstructured":"Carter JD, Inman RD. Chlamydia-induced reactive arthritis: hidden in plain sight? Best Pract Res Clin Rheumatol. 2011;25:359\u201374.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1018_CR14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.idc.2009.10.002","volume":"24","author":"A Burillo","year":"2010","unstructured":"Burillo A, Bouza EP. Chlamydophila pneumoniae. Infect Dis Clin N Am. 2010;24:61\u201371.","journal-title":"Infect Dis Clin N Am"},{"key":"1018_CR15","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s00296-017-3779-1","volume":"37","author":"A Kononoff","year":"2017","unstructured":"Kononoff A, Arstila L, Pussinen P, Kautiainen H, Elfving P, Savolainen E, et al. Incidence of inflammatory joint diseases in Finland: results from a population-based epidemiological study. Rheumatol Int. 2017;37:1693\u2013700.","journal-title":"Rheumatol Int"},{"key":"1018_CR16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jbspin.2017.01.013","volume":"85","author":"A Courcoul","year":"2018","unstructured":"Courcoul A, Brinster A, Decullier E, et al. A bicentre retrospective study of features and outcomes of patients with reactive arthritis. Joint Bone Spine. 2018;85:201\u20135 The French two-centre retrospective study reports that the frequency of ReA in patients hospitalized in rheumatology department did not change between 2002 and 2012 compared with between 1986 and 1996. This is the first study of ReA features over a large period of time of 26 years. In the majority of cases, the diagnosis is based on clinical characteristics alone, as microorganism could not be identified by culture or PCR in synovial fluid or by serology. The trigger for infection was predominantly urogenital and gastrointestinal, with similar distribution in both cohorts. However, some \u201catypical\u201d triggers, such as Escherichia coli, Mycoplasma, Streptococcus pyogenes, Mycobacterium bovis after bacillus Calmette-Gu\u00e9rin immunotherapy, and Strongyloides stercoralis, were found in the 2002\u20132012 cohort and not in the 1986\u20131996 cohort.","journal-title":"Joint Bone Spine"},{"key":"1018_CR17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.reuma.2016.08.001","volume":"14","author":"A Brinster","year":"2018","unstructured":"Brinster A, Guillot X, Prati C, Wendling D. Evolution over thirty years of the profile of inpatients with reactive arthritis in a tertiary rheumatology unit. Reumatol Clin. 2018;14:36\u20139.","journal-title":"Reumatol Clin"},{"key":"1018_CR18","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1007\/s10067-019-04522-4","volume":"38","author":"KM Hayes","year":"2019","unstructured":"Hayes KM, RJP H, Turk MA, Pope JE. Evolving patterns of reactive arthritis. Clin Rheumatol. 2019;38:2083\u20138 Members (n=548) of the Canadian Rheumatology Association were surveyed with questions covering their demographic information, subspecialty, level of experience, practice setting and opinions on prevalence, treatment, and causes of ReA. Although the response rate was only 18% limiting the generalizability, there were however no differences between respondents with respect to type of practice and experience. ReA may be decreasing in frequency and severity (less than full triad of symptoms and less chronic ReA) in Canada. Changes could be due to less food-borne illness, cleaner water, more rapid treatment of sexually transmitted infections, or mutations of common infectious causes of ReA to strains with less chance of producing an immune response (less arthritogenic) but this is speculative.","journal-title":"Clin Rheumatol"},{"key":"1018_CR19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11926-019-0863-4","volume":"21","author":"H Zeidler","year":"2019","unstructured":"Zeidler H, Hudson AP. Chlamydia-induced reactive arthritis: disappearing entity or lack of research? Curr Rheumatol Rep. 2019;21:63 The review highlights that epidemiological studies have indicated a diversity of the incidence and frequency of Chlamydia-associated ReA in different parts of the world, with evidence of declining incidence in some regions. The overall number of published primary research reports and reviews focused on Chlamydia-induced ReA has declined significantly in recent years raising the question whether the entity is in fact disappearing or whether it is simply being underdiagnosed or underreported.","journal-title":"Curr Rheumatol Rep"},{"key":"1018_CR20","doi-asserted-by":"publisher","unstructured":"Klingebiel S, Rieger H, Gosheger G, Theil JC, Rickert C, Schneider KN. Postinfectious reactive arthritis after Chlamydia infection in competitive sports: Clinical management and current literature review. (in German) Orthop\u00e4de. 2020. German. doi: https:\/\/doi.org\/10.1007\/s00132-020-03935-3","DOI":"10.1007\/s00132-020-03935-3"},{"key":"1018_CR21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4103\/idoj.IDOJ_410_19","volume":"11","author":"M Sharma","year":"2020","unstructured":"Sharma M, Sharma S, Sharma A, Sharma K. Chlamydia trachomatis associated reactive arthritis: a urinary PCR based study. Indian Dermatol Online J. 2020;11:21\u20134 This is the first study showing that urinary PCR can also be used for the rapid diagnosis of ReA associated with C. trachomatis. PCR using specific primers for C. trachomatis was carried out from urine samples of 65 patients with ReA, 20 of other inflammatory arthritis, and 20 healthy controls. PCR was positive in 24 (36%) of the ReA patients and was negative in all patients of other inflammatory arthritis as well as in normal healthy control group.","journal-title":"Indian Dermatol Online J"},{"key":"1018_CR22","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s11926-012-0280-4","volume":"14","author":"D Morris","year":"2012","unstructured":"Morris D, Inman RD. Reactive arthritis: developments and challenges in diagnosis and treatment. Curr Rheumatol Rep. 2012;14:390\u20134.","journal-title":"Curr Rheumatol Rep"},{"key":"1018_CR23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/01.JAA.0000558320.47868.2f","volume":"32","author":"M Pennisi","year":"2019","unstructured":"Pennisi M, Perdue J, Roulston T, Nicholas J, Schmidt E, Rolfs J. An overview of reactive arthritis. JAAPA. 2019;32:25\u20138.","journal-title":"JAAPA."},{"key":"1018_CR24","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s10067-018-4022-5","volume":"37","author":"A Garc\u00eda-Kutzbach","year":"2018","unstructured":"Garc\u00eda-Kutzbach A, Chac\u00f3n-S\u00fachite J, Garc\u00eda-Ferrer H, Iraheta I. Reactive arthritis: update 2018. Clin Rheumatol. 2018;37:869\u201374 The review shows a complete list of the arthritogenic agents which are reported to be associated with the development of ReA. The authors believe that the prevalence of ReA has been underestimated because of the multiple clinical manifestations, different degrees of disease activity, and geographical and genetical differences that make the diagnosis many times more difficult, although the disease may be as common as rheumatoid arthritis.","journal-title":"Clin Rheumatol"},{"key":"1018_CR25","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/jdv.12741","volume":"29","author":"PG Stavropoulos","year":"2015","unstructured":"Stavropoulos PG, Soura E, Kanelleas A, Katsambas A, Antoniou C. Reactive arthritis. J Eur Acad Dermatol Venereol. 2015;29:415\u201324.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1018_CR26","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.berh.2015.04.019","volume":"29","author":"C Fox","year":"2015","unstructured":"Fox C, Walker-Bone K. Evolving spectrum of HIV-associated rheumatic syndromes. Best Pract Res Clin Rheumatol. 2015;29:244\u201358.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1018_CR27","doi-asserted-by":"crossref","first-page":"bcr2017223537","DOI":"10.1136\/bcr-2017-223537","volume":"2018","author":"K Kawahara","year":"2018","unstructured":"Kawahara K, Mukai T, Miyaji Y, Morita Y. Chronic reactive arthritis associated with prostatitis caused by Neisseria meningitidis. BMJ Case Rep. 2018;2018:bcr2017223537.","journal-title":"BMJ Case Rep"},{"key":"1018_CR28","first-page":"232470961876768","volume":"6","author":"A Marwat","year":"2018","unstructured":"Marwat A, Mehmood H, Hussain A, Khan M, Ullah A, Joshi M. Clostridium difficile colitis leading to reactive arthritis: a rare complication associated with a common disease. J Investig Med High Impact Case Rep. 2018;6:2324709618767689.","journal-title":"J Investig Med High Impact Case Rep"},{"key":"1018_CR29","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10067-007-0710-2","volume":"27","author":"J Birnbaum","year":"2008","unstructured":"Birnbaum J, Bartlett JG, Gelber AC. Clostridium difficile: an under-recognized cause of reactive arthritis? Clin Rheumatol. 2008;27:253\u20135.","journal-title":"Clin Rheumatol"},{"key":"1018_CR30","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/annrheumdis-2019-216736","volume":"79","author":"R Tuompo","year":"2020","unstructured":"Tuompo R, L\u00e4\u00e4veri T, Hannu T, Pakkanen SH, Kirveskari J, Leirisalo-Repo M, et al. Reactive arthritis and other musculoskeletal symptoms associated with acquisition of diarrhoeagenic Escherichia coli (DEC). Ann Rheum Dis. 2020;79:605\u201311 This is the first prospective study to have employed multivariate analysis in investigating whether reactive musculoskeletal symptoms are associated with acquisition of DEC and determining the incidence of enterogenic ReA among travellers with DEC. The prospective study design allowed the very first evaluation of the incidence of ReA and various reactive musculoskeletal symptoms among individuals with travel-acquired DEC.","journal-title":"Ann Rheum Dis"},{"key":"1018_CR31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/1756-185X.13113","volume":"21","author":"M Singh Sangha","year":"2018","unstructured":"Singh Sangha M, Wright ML, Ciurtin C. Strongly positive anti-CCP antibodies in patients with sacroiliitis or reactive arthritis post-E. coli infection: a mini case-series based review. Int J Rheum Dis. 2018;21:315\u201332.","journal-title":"Int J Rheum Dis"},{"key":"1018_CR32","doi-asserted-by":"crossref","first-page":"e228513","DOI":"10.1136\/bcr-2018-228513","volume":"12","author":"GL Erre","year":"2019","unstructured":"Erre GL, Colombo E, Bibb\u00f2 S, Dore MP. Reactive arthritis secondary to Hafnia alvei enterocolitis. BMJ Case Rep. 2019;12:e228513.","journal-title":"BMJ Case Rep"},{"key":"1018_CR33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5339\/qmj.2020.25","volume":"2020","author":"L Alamlih","year":"2020","unstructured":"Alamlih L, Abufaied M, Al-Allaf AW. An unusual cause of reactive arthritis with urticarial: a case report. Qatar Med J. 2020;2020:25 The first case report of on an unusual cause of ReA and urticaria caused by Blastocystis.","journal-title":"Qatar Med J"},{"issue":"6","key":"1018_CR34","first-page":"19","volume":"2","author":"EM Hussein","year":"2019","unstructured":"Hussein EM, El-Hamshary EM, Omar AS, Mokhtaret AB. Parasitic rheumatism among patients infected with intestinal parasites. Acta Sci Gastrointest Disord. 2019;2(6):19\u201323.","journal-title":"Acta Sci Gastrointest Disord"},{"key":"1018_CR35","doi-asserted-by":"crossref","first-page":"18.304","DOI":"10.7812\/TPP\/18.304","volume":"23","author":"C Chun","year":"2019","unstructured":"Chun C, Kingsbury DJ. Poststreptococcal reactive arthritis: diagnostic challenges. Perm J. 2019;23:18.304.","journal-title":"Perm J"},{"key":"1018_CR36","first-page":"33","volume":"29","author":"R Sood","year":"1999","unstructured":"Sood R, Wali JP, Handa R. Poncet\u2019s disease in a north Indian hospital. Trop Dr. 1999;29:33\u20136.","journal-title":"Trop Dr"},{"key":"1018_CR37","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/1756-185X.12726","volume":"19","author":"A Sharma","year":"2016","unstructured":"Sharma A, Pinto B, Dogra S, Sharma K, Goyal P, Sagar V, et al. A case series and review of Poncet\u2019s disease, and the utility of current diagnostic criteria. Int J Rheum Dis. 2016;19:1010\u20137.","journal-title":"Int J Rheum Dis"},{"key":"1018_CR38","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4081\/reumatismo.2019.1114","volume":"71","author":"V Shobha","year":"2019","unstructured":"Shobha V, Desai AM. Poncet\u2019s disease diagnostic criteria decodes conundrum: Poncet\u2019s vs pseudo Poncet\u2019s. Reumatismo. 2019;71:46\u201350 The case series demonstrates that the Sharma and Pinto diagnostic criteria performed very well in routine clinical practice. The result of the study can give guidance to clinicians in making the rare diagnosis in relation to a common infection in endemic areas.","journal-title":"Reumatismo"},{"key":"1018_CR39","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.abd.2019.08.031","volume":"95","author":"JOA Calado","year":"2020","unstructured":"Calado JOA, Miola AC, Silvares MRC, Marques SA. Disseminated tuberculosis associated with reactive arthritis of Poncet in an immunocompetent patient. An Bras Dermatol. 2020;95:343\u20136.","journal-title":"An Bras Dermatol"},{"key":"1018_CR40","doi-asserted-by":"crossref","first-page":"e18008","DOI":"10.1097\/MD.0000000000018008","volume":"98","author":"Y Endo","year":"2019","unstructured":"Endo Y, Kawashiri SY, Koga T, Okamoto M, Tsuji S, Takatani A, et al. Reactive arthritis induced by active extra-articular tuberculosis: a case report. Medicine (Baltimore). 2019;98:e18008.","journal-title":"Medicine (Baltimore)"},{"key":"1018_CR41","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s10067-005-0085-1","volume":"25","author":"M Harjacek","year":"2006","unstructured":"Harjacek M, Ostojic J, Djakovic RO. Juvenile spondyloarthropathies associated with Mycoplasma pneumoniae infection. Clin Rheumatol. 2006;25:470\u20135.","journal-title":"Clin Rheumatol"},{"key":"1018_CR42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s13256-020-02479-6","volume":"14","author":"G Pilianidis","year":"2020","unstructured":"Pilianidis G, Tsinari A, Pandis D, Tsolakidou H, Petridis N. Chronic seronegative spondyloarthropathy following acute Mycoplasma pneumoniae infection in a human leukocyte antigen B27-positive patient: a case report. J Med Case Rep. 2020;14:155.","journal-title":"J Med Case Rep"},{"key":"1018_CR43","doi-asserted-by":"crossref","first-page":"535","DOI":"10.14740\/jocmr3421w","volume":"10","author":"B Bajantri","year":"2018","unstructured":"Bajantri B, Venkatram S, Diaz-Fuentes G. Mycoplasma pneumoniae: a potentially severe infection. J Clin Med Res. 2018;10:535\u201344.","journal-title":"J Clin Med Res"},{"key":"1018_CR44","doi-asserted-by":"crossref","first-page":"E37","DOI":"10.5489\/cuaj.4759","volume":"12","author":"DC Cheung","year":"2018","unstructured":"Cheung DC, Millman AL, Hamilton RJ. Case: Bacillus Calmette-Guerin (BCG)-induced Reiter syndrome with an attempt at repeat BCG induction. Can Urol Assoc J. 2018;12:E37\u20139.","journal-title":"Can Urol Assoc J"},{"key":"1018_CR45","first-page":"001448","volume":"7","author":"M Freixa","year":"2020","unstructured":"Freixa M, \u00daria S, da Silva GN. Reactive arthritis - a rare complication of intravesical BCG instillation. Eur J Case Rep Intern Med. 2020;7:001448.","journal-title":"Eur J Case Rep Intern Med"},{"key":"1018_CR46","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10396-018-0889-7","volume":"46","author":"H Yoshimura","year":"2019","unstructured":"Yoshimura H, Okano T, Inui K, Nakamura H. Ultrasonographic findings in a patient with reactive arthritis induced by intravesical BCG therapy for bladder cancer. J Med Ultrason (2001). 2019;46:163\u20135.","journal-title":"J Med Ultrason (2001)"},{"key":"1018_CR47","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.therap.2019.01.011","volume":"74","author":"M Slouma","year":"2019","unstructured":"Slouma M, Chammakhi M, Dhahri R, Metoui L, Boussetta N, Ajili F, et al. Unusual evolution of reactive arthritis induced by BCG therapy. Therapie. 2019;74:685\u20138.","journal-title":"Therapie."},{"key":"1018_CR48","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1007\/s00296-019-04330-8","volume":"39","author":"AH Redford","year":"2019","unstructured":"Redford AH, Trost JR, Sibbitt WL Jr, Fangtham M, Emil NS, Singh S, et al. HLA-B27 spondyloarthritis and spotted fever rickettsiosis: case-based review. Rheumatol Int. 2019;39:1643\u201350.","journal-title":"Rheumatol Int"},{"key":"1018_CR49","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.anaerobe.2015.12.011","volume":"38","author":"P Legendre","year":"2016","unstructured":"Legendre P, Lalande V, Eckert C, Barbut F, Fardet L, Meynard JL, et al. Clostridium difficile associated reactive arthritis: case report and literature review. Anaerobe. 2016;38:76\u201380.","journal-title":"Anaerobe."},{"key":"1018_CR50","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/ard.55.8.564","volume":"55","author":"G Kingsley","year":"1996","unstructured":"Kingsley G, Sieper J. Third International Workshop on Reactive Arthritis. 23-26 September 1995, Berlin, Germany. Report and abstracts. Ann Rheum Dis. 1996;55:564\u201384.","journal-title":"Ann Rheum Dis"},{"key":"1018_CR51","first-page":"1338","volume":"26","author":"C Pacheco-Tena","year":"1999","unstructured":"Pacheco-Tena C, Burgos-Vargas R, V\u00e1zquez-Mellado J, Cazar\u00edn J, P\u00e9rez-D\u00edaz JA. A proposal for the classification of patients for clinical and experimental studies on reactive arthritis. J Rheumatol. 1999;26:1338\u201346.","journal-title":"J Rheumatol"},{"key":"1018_CR52","doi-asserted-by":"crossref","first-page":"R40","DOI":"10.1186\/ar2398","volume":"10","author":"M Siala","year":"2008","unstructured":"Siala M, Jaulhac B, Gdoura R, Sibilia J, Fourati H, Younes M, et al. Analysis of bacterial DNA in synovial tissue of Tunisian patients with reactive and undifferentiated arthritis by broad-range PCR, cloning and sequencing. Arthritis Res Ther. 2008;10:R40.","journal-title":"Arthritis Res Ther"},{"key":"1018_CR53","doi-asserted-by":"crossref","first-page":"R102","DOI":"10.1186\/ar2748","volume":"11","author":"M Siala","year":"2009","unstructured":"Siala M, Gdoura R, Fourati H, Rihl M, Jaulhac B, Younes M, et al. Broad-range PCR, cloning and sequencing of the full 16S rRNA gene for detection of bacterial DNA in synovial fluid samples of Tunisian patients with reactive and undifferentiated arthritis. Arthritis Res Ther. 2009;11:R102.","journal-title":"Arthritis Res Ther"},{"key":"1018_CR54","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1053\/sarh.2002.30441","volume":"31","author":"SL Peng","year":"2002","unstructured":"Peng SL. Rheumatic manifestations of parasitic diseases. Semin Arthritis Rheum. 2002;31:228\u201347.","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"1018_CR55","doi-asserted-by":"crossref","first-page":"e0200645","DOI":"10.1371\/journal.pone.0200645","volume":"13","author":"M Herbette","year":"2018","unstructured":"Herbette M, Cren JB, Joffres L, Lucas C, Ricard E, Salliot C, et al. Usefulness of polymerase chain reaction for diagnosing Whipple's disease in rheumatology. PLoS One. 2018;13(7):e0200645.","journal-title":"PLoS One"},{"key":"1018_CR56","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/cid\/ciy614","volume":"68","author":"SE Schutzer","year":"2019","unstructured":"Schutzer SE, Body BA, Boyle J, Branson BM, Dattwyler RJ, Fikrig E, et al. Direct diagnostic tests for Lyme disease. Clin Infect Dis. 2019;68:1052\u20137.","journal-title":"Clin Infect Dis"},{"key":"1018_CR57","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/pathogens9020091","volume":"9","author":"T Meyer","year":"2020","unstructured":"Meyer T, Buder S. The laboratory diagnosis of Neisseria gonorrhoeae: current testing and future demands. Pathogens. 2020;9:91.","journal-title":"Pathogens."},{"issue":"3","key":"1018_CR58","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/art.1780400334","volume":"40","author":"T Schaeverbeke","year":"1997","unstructured":"Schaeverbeke T, B\u00e9b\u00e9ar C, Bannwarth B, B\u00e9b\u00e9ar C, Dehais J. Reactive or septic arthritis? Comment on the article by Li et al. Arthritis Rheum. 1997;40(3):592\u20133.","journal-title":"Arthritis Rheum"},{"key":"1018_CR59","first-page":"2050313X1982824","volume":"7","author":"D Gaut","year":"2019","unstructured":"Gaut D, Muir K, Pessegueiro AM. A case of Staphylococcus lugdunensis bacteremia complicated by reactive arthritis. SAGE Open Med Case Rep. 2019;7:2050313X19828249.","journal-title":"SAGE Open Med Case Rep"},{"key":"1018_CR60","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1097\/PHM.0000000000001418","volume":"99","author":"H Madhoun","year":"2020","unstructured":"Madhoun H, Landry K, Baria MR. Induction of HLA-B27-associated reactive arthritis after a Wharton\u2019s jelly \u201cstem cell\u201d injection: a case report. Am J Phys Med Rehabil. 2020;99:e142\u20135. https:\/\/doi.org\/10.1097\/PHM.0000000000001418.","journal-title":"Am J Phys Med Rehabil"},{"key":"1018_CR61","doi-asserted-by":"publisher","first-page":"e303","DOI":"10.1097\/RHU.0000000000001157","volume":"26","author":"T Horino","year":"2019","unstructured":"Horino T, Inotani S, Matsumoto T, Ichii O, Terada Y. Reactive arthritis caused by Rothia mucilaginosa in an elderly diabetic patient. J Clin Rheumatol. 2019;26:e303\u20134. https:\/\/doi.org\/10.1097\/RHU.0000000000001157.","journal-title":"J Clin Rheumatol"},{"key":"1018_CR62","doi-asserted-by":"publisher","first-page":"e001350","DOI":"10.1136\/rmdopen-2020-001350","volume":"6","author":"K Ono","year":"2020","unstructured":"Ono K, Kishimoto M, Shimasaki T, Uchida H, Kurai D, Deshpande GA, et al. Reactive arthritis after COVID-19 infection. RMD Open. 2020;6:e001350. https:\/\/doi.org\/10.1136\/rmdopen-2020-001350.","journal-title":"RMD Open"},{"issue":"8","key":"1018_CR63","first-page":"e9698","volume":"12","author":"Z Danssaert","year":"2020","unstructured":"Danssaert Z, Raum G, Hemtasilpa S. Reactive arthritis in a 37-year-old female with SARS-CoV2 infection. Cureus. 2020;12(8):e9698.","journal-title":"Cureus."},{"key":"1018_CR64","doi-asserted-by":"publisher","unstructured":"Yokogawa N, Minematsu N, Katano H, Suzuki T. Case of acute arthritis following SARS-CoV-2 infection. Ann Rheum Dis. 2020:annrheumdis-2020-218281. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218281.","DOI":"10.1136\/annrheumdis-2020-218281"},{"issue":"6","key":"1018_CR65","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/RHU.0000000000001560","volume":"26","author":"IY Liew","year":"2020","unstructured":"Liew IY, Mak TM, Cui L, Vasoo S, Lim XR. A case of reactive arthritis secondary to coronavirus disease 2019 infection. J Clin Rheumatol. 2020 Sep;26(6):233.","journal-title":"J Clin Rheumatol"},{"key":"1018_CR66","doi-asserted-by":"publisher","unstructured":"De Stefano L, Rossi S, Montecucco C, Bugatti S. Transient monoarthritis and psoriatic skin lesions following COVID-19. Ann Rheum Dis. 2020:annrheumdis-2020-218520. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218520.","DOI":"10.1136\/annrheumdis-2020-218520"},{"key":"1018_CR67","doi-asserted-by":"publisher","unstructured":"Schenker HM, Hagen M, Simon D, Schett G, Manger B. Reactive arthritis and cutaneous vasculitis after SARS-CoV-2 infection. Rheumatology (Oxford). 2020 :keaa689. https:\/\/doi.org\/10.1093\/rheumatology\/keaa689.","DOI":"10.1093\/rheumatology\/keaa689"},{"key":"1018_CR68","doi-asserted-by":"crossref","first-page":"0101","DOI":"10.24966\/CSMC-8801\/100101","volume":"7","author":"IG Mukarram","year":"2020","unstructured":"Mukarram IG, Mukarram MS, Ishaq K, Riaz SU. Post COVID-19 reactive arthritis: an emerging existence in the spectrum of musculoskeletal complications of SARS-CoV-2 infection. J Clin Stud Med Case Rep. 2020;7:0101.","journal-title":"J Clin Stud Med Case Rep"},{"key":"1018_CR69","first-page":"e11761","volume":"12","author":"I Jali","year":"2020","unstructured":"Jali I. Reactive arthritis after COVID-19 Infection. Cureus. 2020;12:e11761.","journal-title":"Cureus."},{"key":"1018_CR70","doi-asserted-by":"publisher","first-page":"105086","DOI":"10.1016\/j.jbspin.2020.105086","volume":"27","author":"D Wendling","year":"2020","unstructured":"Wendling D, Verhoeven F, Chouk M, Prati C. Can SARS-CoV-2 trigger reactive arthritis? Joint Bone Spine. 2020;27:105086. https:\/\/doi.org\/10.1016\/j.jbspin.2020.105086The overview discusses case reports of acute arthritis or dactylitis associated with SARS-CoV-2 infection, some of which may be suggestive of reactive arthritis. Potential hypothetic mechanisms involved in the pathogenesis of the arthritis are introduced.","journal-title":"Joint Bone Spine"},{"key":"1018_CR71","doi-asserted-by":"publisher","unstructured":"Graef ER, Liew JW, Kim AH, Sparks JA. Response to: \u2018Case series of acute arthritis in COVID-19 admission\u2019 by L\u00f3pez-Gonz\u00e1lez et al. Ann Rheum Dis. 2020:annrheumdis-2020-217989. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217989.","DOI":"10.1136\/annrheumdis-2020-217989"},{"key":"1018_CR72","doi-asserted-by":"publisher","unstructured":"Lopez-Gonzalez M, Peral-Garrido ML, Calabuig I. A case series of acute arthritis during COVID-19 admission. Ann Rheum Dis. 2020. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217914.","DOI":"10.1136\/annrheumdis-2020-217914"},{"key":"1018_CR73","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/1756-185X.12941","volume":"20","author":"PC Robinson","year":"2017","unstructured":"Robinson PC, Kempe S, Tebbutt I, Roberts L. Epidemiology of inpatient gout in Australia and New Zealand: temporal trends, comorbidities and gout flare site. Int J Rheum Dis. 2017;20:779\u201384.","journal-title":"Int J Rheum Dis"},{"key":"1018_CR74","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.idc.2017.01.002","volume":"31","author":"SK Schmitt","year":"2017","unstructured":"Schmitt SK. Reactive arthritis. Infect Dis Clin N Am. 2017;31:265\u201377.","journal-title":"Infect Dis Clin N Am"},{"key":"1018_CR75","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/1744666X.2017.1233816","volume":"13","author":"JD Carter","year":"2017","unstructured":"Carter JD, Hudson AP. Recent advances and future directions in understanding and treating Chlamydia-induced reactive arthritis. Expert Rev Clin Immunol. 2017;13:197\u2013206.","journal-title":"Expert Rev Clin Immunol"},{"key":"1018_CR76","first-page":"534","volume":"14","author":"A Dumusc","year":"2018","unstructured":"Dumusc A, Hugle T. L\u2019arthrite r\u00e9actionnelle. Rev Med Suisse. 2018;14:534\u20137.","journal-title":"Rev Med Suisse"},{"key":"1018_CR77","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.3390\/biom10101461","volume":"10","author":"A Sharip","year":"2020","unstructured":"Sharip A, Kunz J. Understanding the pathogenesis of spondyloarthritis. Biomolecules. 2020;10:1461. https:\/\/doi.org\/10.3390\/biom10101461.","journal-title":"Biomolecules"},{"key":"1018_CR78","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3390\/microorganisms8040482","volume":"8","author":"S Mousave","year":"2020","unstructured":"Mousave S, Bereswill S, Heimesaat MM. Novel clinical Campylobacter jejuni infection models based on sensitization of mice to lipooligosaccharide, a major bacterial factor triggering innate immune responses in human campylobacteriosis. Microorganisms. 2020;8:482. https:\/\/doi.org\/10.3390\/microorganisms8040482.","journal-title":"Microorganisms"},{"key":"1018_CR79","doi-asserted-by":"publisher","first-page":"15131","DOI":"10.1038\/s41598-020-71674-8","volume":"10","author":"A Verma","year":"2020","unstructured":"Verma A, Sharda S, Rathi B, Somvanshi V, Pandey BD. Elucidating potential molecular signatures through host-microbe interactions for reactive arthritis and inflammatory bowel disease using combinatorial approach. Sci Rep. 2020;10:15131. https:\/\/doi.org\/10.1038\/s41598-020-71674-8.","journal-title":"Sci Rep"},{"key":"1018_CR80","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00000441-200103000-00003","volume":"321","author":"A Iglesias-Gamarra","year":"2001","unstructured":"Iglesias-Gamarra A, Mendez EA, Cuellar ML, Ponce de Leon JH, Jimenez C, Canas C, et al. Poststreptococcal reactive arthritis in adults: long-term follow-up. Am J Med Sci. 2001;321:173\u20137.","journal-title":"Am J Med Sci"},{"key":"1018_CR81","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/rheumatology\/keh225","volume":"43","author":"SL Mackie","year":"2004","unstructured":"Mackie SL, Keat A. Poststreptococcal reactive arthritis: what is it and how do we know it. Rheumatology. 2004;43:949\u201354.","journal-title":"Rheumatology"},{"key":"1018_CR82","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1007\/s10067-019-04715-x","volume":"38","author":"KI Vega-Villanueva","year":"2019","unstructured":"Vega-Villanueva KI, Espinoza LR. Expanding the spectrum of spondyloarthritis (SpA), post-streptococcal reactive arthritis- (PSRA) related psoriatic spondyloarthritis (PSpA). Clin Rheumatol. 2019;38:2363\u20135.","journal-title":"Clin Rheumatol"},{"key":"1018_CR83","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1007\/s10067-019-04695-y","volume":"38","author":"A Daga","year":"2019","unstructured":"Daga A, Dahan S, Shemer A, Langevitz P, Hellou T, Davidson T, et al. Acute onset of psoriatic spondyloarthritis as a new manifestation of post-streptococcal reactive arthritis: a case series. Clin Rhematol. 2019;38:2367\u201372.","journal-title":"Clin Rhematol"},{"key":"1018_CR84","first-page":"1827","volume":"29","author":"HC G\u00e9rard","year":"2002","unstructured":"G\u00e9rard HC, Wang Z, Whittum-Hudson JA, Bardin T, Schumacher HR, Hudson AP. Cytokine and chemokine mRNA produced in synovial tissue chronically infected with C trachomatis and Chlamydia pneumoniae. J Rheumatol. 2002;29:1827\u201335.","journal-title":"J Rheumatol"},{"key":"1018_CR85","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/mpat.2000.0360","volume":"29","author":"HC G\u00e9rard","year":"2000","unstructured":"G\u00e9rard HC, Schumacher HR, El-Gabalawy H, Goldbach-Mansky R, Hudson AP. Chlamydia pneumoniae infecting the human synovium are viable and metabolically active. Microb Pathog. 2000;29:17\u201324.","journal-title":"Microb Pathog"},{"key":"1018_CR86","doi-asserted-by":"publisher","first-page":"p1","DOI":"10.1007\/s40588-020-00152-6","volume":"26","author":"B Ibtissam","year":"2020","unstructured":"Ibtissam B, Abdelgahni KB, Rostom S, Amine B, Laatar A, Bahiri R. Reactive arthritis: update. Curr Clin Microbiol Rep. 2020;26:p1\u20139. https:\/\/doi.org\/10.1007\/s40588-020-00152-6.","journal-title":"Curr Clin Microbiol Rep"},{"key":"1018_CR87","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1055\/a-1036-9359","volume":"145","author":"E Marker-Hermann","year":"2020","unstructured":"Marker-Hermann E. Reactive arthritis \u2013 a disease almost forgotten? (in German). Dtsch Med Wochenschr. 2020;145:1786\u20130.","journal-title":"Dtsch Med Wochenschr"},{"key":"1018_CR88","first-page":"503","volume":"12","author":"A Finckh","year":"2016","unstructured":"Finckh A. Reactive arthritis \u2013 inflammation or true infection? (in French). Rev Med Suisse. 2016;12:503\u20136.","journal-title":"Rev Med Suisse"},{"key":"1018_CR89","doi-asserted-by":"publisher","unstructured":"Saricaoglu EM, Hasanoglu I, Guner R. The first reactive arthritis case associated with COVID-19. J Med Virol. 2020;fragata 11. https:\/\/doi.org\/10.1002\/jmv.26296.","DOI":"10.1002\/jmv.26296"},{"key":"1018_CR90","first-page":"278","volume":"45","author":"I Fragata","year":"2020","unstructured":"Fragata I, Mourao AF. Coronavirus disease 19 (COVID-19) complicated with post-viral arthritis. Acta Rheumatol Port. 2020;45:278\u201380.","journal-title":"Acta Rheumatol Port"},{"key":"1018_CR91","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/s41598-019-55730-6","volume":"10","author":"SSK Venigalla","year":"2020","unstructured":"Venigalla SSK, Premakumar S, Janakiraman V. A possible role for autoimmunity through molecular mimicry in alphavirus mediated arthritis. Sci Rep. 2020;10:938. https:\/\/doi.org\/10.1038\/s41598-019-55730-6.","journal-title":"Sci Rep"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-021-01018-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-021-01018-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-021-01018-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:24:46Z","timestamp":1744176286000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-021-01018-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":91,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["1018"],"URL":"https:\/\/doi.org\/10.1007\/s11926-021-01018-6","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"21 April 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"53"}}